BCL2L11 and ovarian carcinoma: The dual PI3K/mTOR inhibitor NVP-BEZ235 that decreases Mcl-1 expression, synergized with ABT-737 in inducing apoptosis of ovarian carcinoma cells, provided that Bim expression was induced [575].